Managed Healthcare Executive Newsletter

To view this email as a web page, click here.

TOP STORIES

The Trump Administration has taken a large interest in PBM drug rebates, which they say create higher drug prices. But do they?

The Promises and Challenges of Gene Therapy

Gene therapy offers great hope for patients, but comes with a bevy of challenges for patients and payers alike.

FDA Issues Biosimilar Naming Guidance

FDA issued a lengthy statement on biosimilar naming conventions—but industry groups worry it will disincentivize biosimilar development

DIGITAL EDITION

Check out our March issue featuring:

• Innovation Transforms Healthcare
• Seven Tactics to Create a Lifetime Healthcare Consumer
• A Closer Look at Employer-Sponsored Healthcare

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.